$772K sweet spot round size
Most of their 104 investments are in rounds between $23M and $80M
2017
ROME Therapeutics raised $72M on September 12, 2023
Investors: Bristol-Myers Squibb, UK, Sanofi Ventures, GV, Casdin Capital, LLC and Section 32
Undisclosed raised $100M on September 7, 2023
Investors: Andreessen Horowitz, Obvious Ventures and Section 32
Endor Labs raised $70M on August 3, 2023
Investors: Lightspeed Venture Partners, Coatue Management, Dell Technologies Capital and Section 32
Octave Bioscience raised $30M on July 26, 2023
Investors: Northpond Ventures, Hikma Ventures, Casdin Capital, LLC, Intermountain Ventures, ECHO and Section 32
Undisclosed raised $53M on June 22, 2023
Investors: Senator Investment Group LP, Partners Investment and Section 32
Delve Bio raised $35M on June 20, 2023
Investors: Xontogeny, GV and Section 32
Function Oncology raised $28M on April 12, 2023
Investors: Andreessen Horowitz, Casdin Capital, LLC and Section 32
Faro Health Inc. raised $20M on February 8, 2023
Investors: Polaris Partners, Zetta Venture Partners, General Catalyst, Northpond Ventures and Section 32
Forward Networks raised $50M on January 24, 2023
Investors: Threshold Ventures, Omega Venture Partners, BDT & MSD Partners, A.Capital Ventures, Andreessen Horowitz and Section 32
MedCrypt raised $25M on November 1, 2022
Investors: Intuitive Ventures, Anzu Partners, Dolby Family Ventures, Eniac Ventures and Section 32